Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sequencing of therapy to avoid resistance and the need for new antiretroviral drugs in the treatment of HIV disease.

Infectious disorders drug targets - 1 Apr 2009

Wainberg Mark A, Martinez-Cajas Jorge L

Abstract excerpt

HIV-1 drug regimens now offer more potent, less toxic and more durable choices. However, strategies addressing convenient sequential use of active antiretroviral combinations are rarely presented in the literature. Studies have seldom directly addressed this issue, despite it being a matter of daily use in clinical practice. This is, in part, because of the complexity of HIV-1 resistance information....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Mutation

Source

Identifiers

PMID: 19275705
DOI: 10.2174/187152609787847668

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sequencing of therapy to avoid resistance and the need for new antiretroviral drugs in the treatment of HIV disease.PMID 19275705Read ↗

Antiretroviral therapy : optimal sequencing of therapy to avoid resistance.Semantic proximity Read ↗

Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.Semantic proximity Read ↗

Antiretroviral therapy. Sequencing antiretrovirals.Semantic proximity Read ↗

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.Semantic proximity Read ↗

Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 1).Semantic proximity Read ↗

Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2).Semantic proximity Read ↗

Current knowledge of HIV-1 reverse transcriptase mutations selected during nucleoside analogue therapy: the potential to use resistance data to guide clinical decisions.Semantic proximity Read ↗

Strategies for overcoming resistance in HIV-1 infected patients receiving HAART.Semantic proximity Read ↗

HIV treatment choice based on resistance patterns.Semantic proximity Read ↗

K65R, TAMs and tenofovir.Semantic proximity Read ↗

HIV drug resistance and implications for the introduction of antiretroviral therapy in resource-poor countries.Semantic proximity Read ↗

Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.